High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery

作者: Onur Isık , Olcay Murat Disli , Tolga Bas , Hakan Aydın , Murat Koç

DOI: 10.5935/1678-9741.20140039

关键词:

摘要: Objective: Congenital heart diseases are observed in 5 to 8 of every 1000 live births. The presence a valuable biomarker during the surgical periods may aid clinician more accurate prognosis treatment. Methods: For this reason, surfactant protein B plasma levels help evaluate patients with cardiac problems diminishing alveolocapillary membrane stability. In study, were measured preoperative and postoperative periods. This study was conducted detect differences between pulmonary hypertensive normotensive patients. before after cardiopulmonary bypass examined. Results: time, cross-clamp time , inotropic support dose, duration intensive care without found be statistically significant (P<0.05). results revealed that pathophysiological state related other variables studied. We believe SPB could attributed damage alveolar dysfunction. condition significantly associated parameters. Conclusion: findings current showed present blood congenital disease period. Long by-pass times exert hypertension failure, it is recommended keep option therapy mind course at unit preparing for extubation.

参考文章(17)
Marnie A. Ryan, Henry T. Akinbi, Alicia G. Serrano, Jesus Perez-Gil, Huixing Wu, Francis X. McCormack, Timothy E. Weaver, Antimicrobial Activity of Native and Synthetic Surfactant Protein B Peptides Journal of Immunology. ,vol. 176, pp. 416- 425 ,(2006) , 10.4049/JIMMUNOL.176.1.416
Domingo A. Pascual-Figal, Jesús Sánchez-Más, Gonzalo de la Morena, Teresa Casas, Iris P. Garrido, Juan A. Ruipérez, Mariano Valdés, Pulmonary surfactant protein B in the peripheral circulation and functional impairment in patients with chronic heart failure. Revista Espanola De Cardiologia. ,vol. 62, pp. 136- 142 ,(2009) , 10.1016/S1885-5857(09)71531-2
Jeffrey A. Whitsett, Timothy E. Weaver, Hydrophobic surfactant proteins in lung function and disease. The New England Journal of Medicine. ,vol. 347, pp. 2141- 2148 ,(2002) , 10.1056/NEJMRA022387
Jo Rae Wright, Immunoregulatory functions of surfactant proteins. Nature Reviews Immunology. ,vol. 5, pp. 58- 68 ,(2005) , 10.1038/NRI1528
Steven D. Tennenberg, Chris W. Clardy, Warren W. Bailey, Joseph S. Solomkin, Complement activation and lung permeability during cardiopulmonary bypass The Annals of Thoracic Surgery. ,vol. 50, pp. 597- 601 ,(1990) , 10.1016/0003-4975(90)90196-D
Craig M Cox, Raimondo Ascione, Alan M Cohen, Ian M Davies, Ian G Ryder, Gianni D Angelini, Effect of cardiopulmonary bypass on pulmonary gas exchange: a prospective randomized study. The Annals of Thoracic Surgery. ,vol. 69, pp. 140- 145 ,(2000) , 10.1016/S0003-4975(99)01196-0
Arthur C. Guyton, John E. Hall, Textbook of Medical Physiology ,(1966)
ANDREW D. BERSTEN, TAMARA HUNT, TERRENCE E. NICHOLAS, IAN R. DOYLE, Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure. American Journal of Respiratory and Critical Care Medicine. ,vol. 164, pp. 648- 652 ,(2001) , 10.1164/AJRCCM.164.4.2010111
M. Griese, C. Wilnhammer, S. Jansen *, C. Rinker, Cardiopulmonary bypass reduces pulmonary surfactant activity in infants The Journal of Thoracic and Cardiovascular Surgery. ,vol. 118, pp. 237- 244 ,(1999) , 10.1016/S0022-5223(99)70213-8
Michael A. Matthay, Jeanine P. Wiener-Kronish, Respiratory management after cardiac surgery. Chest. ,vol. 95, pp. 424- 434 ,(1989) , 10.1378/CHEST.95.2.424